- Home
- NBIX vs CNA Comparison
NBIX vs CNA Comparison
Compare NBIX & CNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- CNA
- Stock Information
- Founded
- NBIX 1992
- CNA 1853
- Country
- NBIX United States
- CNA United States
- Employees
- NBIX N/A
- CNA N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- CNA Property-Casualty Insurers
- Sector
- NBIX Health Care
- CNA Finance
- Exchange
- NBIX Nasdaq
- CNA Nasdaq
- Market Cap
- NBIX 14.1B
- CNA 13.2B
- IPO Year
- NBIX 1996
- CNA N/A
- Fundamental
- Price
- NBIX $139.41
- CNA $45.95
- Analyst Decision
- NBIX Strong Buy
- CNA Sell
- Analyst Count
- NBIX 18
- CNA 2
- Target Price
- NBIX $161.50
- CNA $50.50
- AVG Volume (30 Days)
- NBIX 713.3K
- CNA 371.7K
- Earning Date
- NBIX 10-29-2025
- CNA 11-03-2025
- Dividend Yield
- NBIX N/A
- CNA 8.22%
- EPS Growth
- NBIX 2.97
- CNA N/A
- EPS
- NBIX 3.39
- CNA 3.22
- Revenue
- NBIX $2,509,900,000.00
- CNA $14,651,000,000.00
- Revenue This Year
- NBIX $20.66
- CNA N/A
- Revenue Next Year
- NBIX $14.64
- CNA $24.00
- P/E Ratio
- NBIX $41.44
- CNA $14.50
- Revenue Growth
- NBIX 18.42
- CNA 6.12
- 52 Week Low
- NBIX $84.23
- CNA $43.29
- 52 Week High
- NBIX $154.61
- CNA $51.42
- Technical
- Relative Strength Index (RSI)
- NBIX 53.05
- CNA 50.82
- Support Level
- NBIX $140.56
- CNA N/A
- Resistance Level
- NBIX $144.04
- CNA $48.04
- Average True Range (ATR)
- NBIX 3.54
- CNA 0.59
- MACD
- NBIX -0.26
- CNA -2.10
- Stochastic Oscillator
- NBIX 35.85
- CNA 92.41
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About CNA CNA Financial Corporation
CNA Financial Corporation (CNAF) is an insurance holding company that provides commercial property and casualty insurance. The company operates under five segments: Specialty, Commercial and International being its core business, and two segments for its non-core businesses, which are Life and Group and Corporate and Other. CNAF, through its segments, provides professional, financial, specialty property, and casualty products to small businesses and medium-scale organizations. It has its business spread across Continental Europe, United Kingdom, and Canada. The majority of the revenues are generated from the Specialty and Commercial segment of the business.